![](/img/cover-not-exists.png)
Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis
Khalilieh, S., Hussain, A., Montgomery, D., Levine, V., Shaw, P.M., Bodrug, I., Mekokishvili, L., Bailey-Smith, C., Glasgow, X.S., Cheng, A., Martinho, M., Iwamoto, M.Language:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13670
Date:
June, 2018
File:
PDF, 603 KB
english, 2018